Topic:

Partnering

Latest Headlines

Latest Headlines

UPDATE: Japan's CiRA, Takeda in clinical pact on stem cell R&D led by Nobel laureate Yamanaka

The Center for iPS Cell Research Application (CiRA) of Kyoto University and Takeda Pharmaceutical Company announced a decade-long R&D effort to discover new applications for induced pluripotent stem cells in areas such as heart failure, diabetes mellitus, neurological disorders and cancer immunotherapy, according to a press release.

Samsung partners to develop next-gen health and wellness software, mobile apps

Samsung, along with several other electronics conglomerates, is working to puzzle out what's next in mobile healthcare. A growing foothold in healthcare could aid these companies, which are vulnerable to the vagaries of eroding profit margins and rapidly evolving technology.

Recipharm bets on a U.S. biotech with an R&D joint venture

Swedish contract drug developer Recipharm has signed a deal with Virginia's Synthonics, investing in the biotech and lending its expertise in the development of new compounds.

Two ophthalmology CROs join forces for ocular R&D

Iris Pharma and Oculos Clinical Research, two CROs focused on the eye, have inked a strategic alliance to boost their profiles in the contracting world.

Aptuit pairs up with an Italian CRO for drug discovery

U.S. contractor Aptuit has signed a deal with Italy's Axxam to team up on early-stage R&D services, pooling their resources to better compete for projects.

Quick China dealmaking as TVM, Lummy tie with Argos on oncology candidate

TVM Capital Life Science moved quickly to tap a new $50 million venture capital fund with investment from Chinese partner Lummy Co. in a licensing deal for an oncology dendritic vaccine.

Alibaba's latest move in China online drug sales is $2.51B shift of Tmall

Alibaba Group Holding aims to ramp up fledgling online drug sales in China by placing online drug retailer Tmall under its listed healthcare unit in a shuffle estimated at $2.51 billion, the company said in a press release.

Taxus Cardium Generx drug development gets amped up investment

A promising angiogenic gene therapy candidate in development for nearly two decades has drawn in further investment from China-based Shenzhen Qianhai Taxus Industry Capital Management, picking up a 15% stake in Angionetics, a newly formed subsidiary of Taxus Cardium Pharmaceuticals Group.

Japan's RegImmune joins with Pfizer on Type 1 diabetes antigen candidate

Japan's RegImmune has joined with Pfizer and the former Juvenile Diabetes Research Foundation in a partnership to collaborate on research for an antigen-specific preventative for Type 1 diabetes. Financial arrangements were not disclosed, but Pfizer is to provide finances and expertise.

Janssen looks to Ichor's electroporation delivery system for hep B jab

San Diego biotech Ichor Medical Systems stands to earn up to $85 million, plus royalties, if its new partnership with Johnson & Johnson's Janssen hits the right notes. The companies announced plans this week to develop DNA vaccines for hepatitis B using Ichor's TriGrid electroporation technology for clinical administration.